Stefaniuk Paulina, Muzyka-Kasietczuk Justyna, Koczkodaj Dorota, Hus Marek, Podhorecka Monika
Department of Family Medicine, Medical University of Lublin, Lublin, Poland.
Department of Hematooncology and Bone Marrow Transplantation, Medical University of Lublin, Lublin, Poland.
Clin Med Insights Oncol. 2025 Mar 21;19:11795549251321360. doi: 10.1177/11795549251321360. eCollection 2025.
Research proved the prognostic significance of the neutrophil-to-lymphocyte ratio (NLR), lymphocyte-to-monocyte ratio (LMR), platelet-to-lymphocyte ratio (PLR), and red blood cell distribution width (RDW) in some hematological malignancies. This study aimed to analyze the role of pretreatment NLR, LMR, PLR, RDW coefficient of variation (RDW-CV), and RDW standard deviation (RDW-SD) as prognostic markers for acute myeloid leukemia (AML).
This retrospective cohort study included 204 patients newly diagnosed with AML in the Department of Hematooncology and Bone Marrow Transplantation of the Medical University of Lublin.
In the univariate models, higher RDW-CV and lower LMR predicted a poorer response to induction chemotherapy (odds ratio [OR] = 1.21, 95% confidence interval [CI95] = [1.09-2.36], < .001; OR = 0.95, CI95 = [0.89-0.99], = .045, respectively). In the multivariate model, age of diagnosis, ECOG (Performance Status Assessment by Eastern Cooperative Oncology Group) score, cytogenetic risk, NLR, and RDW-CV affected the odds of no response to chemotherapy significantly. The risk of progression was influenced by NLR and RDW-CV in the univariate analysis (hazard ratio [HR] = 1.20, CI95 = [1.09-1.33], < .001; HR = 1.10, CI95 = [1.04-1.17], = .002, respectively). In the multivariate settings, cytogenetic risk, leukocyte count, and RDW-CV affected progression free survival (PFS) significantly. Based on univariate models, the risk of death, when overall survival (OS) was taken into account, was influenced by NLR, LMR, and RDW-CV (HR = 1.05, CI95 = [1.00-1.09], = .034; HR = 0.94, CI95 = [0.89-0.98], = .010; HR = 1.06, CI95 = [1.01-1.10], = .014, respectively).
Higher NLR, higher RDW, lower LMR, and possibly lower PLR are poor prognostic factors that may help in the risk stratification of patients with AML.
研究证实中性粒细胞与淋巴细胞比值(NLR)、淋巴细胞与单核细胞比值(LMR)、血小板与淋巴细胞比值(PLR)以及红细胞分布宽度(RDW)在某些血液系统恶性肿瘤中具有预后意义。本研究旨在分析预处理时的NLR、LMR、PLR、RDW变异系数(RDW-CV)和RDW标准差(RDW-SD)作为急性髓系白血病(AML)预后标志物的作用。
这项回顾性队列研究纳入了卢布林医科大学血液肿瘤与骨髓移植科204例新诊断的AML患者。
在单变量模型中,较高的RDW-CV和较低的LMR预示诱导化疗反应较差(比值比[OR]=1.21,95%置信区间[CI95]=[1.09-2.36],P<0.001;OR=0.95,CI95=[0.89-0.99],P=0.045)。在多变量模型中,诊断年龄、东部肿瘤协作组(ECOG)评分、细胞遗传学风险、NLR和RDW-CV显著影响化疗无反应的几率。在单变量分析中,进展风险受NLR和RDW-CV影响(风险比[HR]=1.20,CI95=[1.09-1.33],P<0.001;HR=1.10,CI95=[1.04-1.17],P=0.002)。在多变量分析中,细胞遗传学风险、白细胞计数和RDW-CV显著影响无进展生存期(PFS)。基于单变量模型,考虑总生存期(OS)时,死亡风险受NLR、LMR和RDW-CV影响(HR=1.05,CI95=[1.00-1.09],P=0.034;HR=0.94,CI95=[0.89-0.98],P=0.010;HR=1.06,CI95=[1.01-1.10],P=0.014)。
较高的NLR、较高的RDW、较低的LMR以及可能较低的PLR是不良预后因素,可能有助于AML患者的风险分层。